Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 261

Total Visits per Month

September 2016 October 2016 November 2016 December 2016 January 2017 February 2017 March 2017
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 5 14 24 3 0 0 0

File Downloads

Views
dce-mri abstract.pdf 39

Top Country Views

Views
United States 63
France 46
Canada 30
China 9
Russia 9
United Kingdom 8
Germany 7
Netherlands 5
Sweden 5
Italy 3

Top City Views

Views
Miami Beach 23
Toronto 12
Ottawa 9
Santa Clara 6
Zhengzhou 6
Kansas City 5
Nynäs 5
Calgary 3
Dundas 3
Munich 3